Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;27(12):3428-3433.
doi: 10.1016/j.sjbs.2020.09.034. Epub 2020 Sep 23.

Serum biomarkers differentiating Kawasaki disease from febrile infections: A pilot case-control study

Affiliations

Serum biomarkers differentiating Kawasaki disease from febrile infections: A pilot case-control study

Asad Aziz Khan et al. Saudi J Biol Sci. 2020 Dec.

Abstract

Although some serum biomarkers are elevated in both Kawasaki disease (KD) and infections, these conditions have not been compared by individual or combined biomarkers. The aim of this study, undertaken between January 2016 and May 2018 in a large teaching hospital, was to compare the serum concentration of cytokines, metalloproteinases (MMP) and heat shock protein (HSP) between cases defined as children with Kawasaki disease (KD) and those with febrile infections (controls). Serum concentrations of tumour necrosis factor-alpha (TNF-alpha), interleukins (IL 1beta, 6, and 8), heat shock proteins (HSP 60 and 70) and matrix metalloproteinase (MMP 9) were measured on admission in 17 children under six years of age with a temperature >38.5 °C for ≥five days, and compared between the two groups. The median age was 25 months and the median duration of fever eight days. Seven children were diagnosed with KD and ten had a febrile infection. Only the serum concentrations of IL-6 and TNF-alpha were significantly higher in the former than in the latter group (P = 0.01 and 0.04 respectively). To differentiate between the two groups with the best sensitivity and specificity, the optimal cut-off value for IL-6 was 12.6 pg/mL, and for TNF-alpha 47.9 pg/mL. Their combined increase, however, outperformed their individual concentrations. The characteristic diagnostic "signature" of the combined elevation of IL-6 and TNF-alpha serum levels has the potential, in febrile children, to differentiate early KD from febrile infections, allowing the institution of appropriate therapy.

Keywords: Cytokine; Heat shock protein; Interleukin; Matrix metalloproteinase; Tumour necrosis factor-alpha.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Receiver operating characteristics (ROC) and area under the curve (AUC) of serum IL-6 and TNF levels to differentiate between children with Kawasaki disease (n = 7) and those with febrile infections (n = 10). The optimal cut-off value For IL-6 was 12.6 pg/mL and for TNF-alpha 47.9 pg/mL IL-6: interleukin 6; TNF: tumour necrosis factor.
Fig. 2
Fig. 2
Spider (or radar) chart of base-10 logarithmic serum biomarkers concentrations in children with Kawasaki disease (n = 7) compared to those with febrile infections (n = 10). It compares the performance of each biomarker between both groups by displaying its individual concentration on its own axis. The lines connecting the values on each axis form a polygon area which represent the magnitude of the biomarkers profile in each group and the overall differences are displayed by the size and shape of the polygons. For each biomarker, the magnitude of its value in each of the two polygon areas indicates the degree of its contribution to the panel performance. The concentrations are shown on a logarithmic scale because of the large number of biomarkers spanning a wide range of values, with many orders of magnitude, and to avoid skewness towards large values; IL: interleukin; TNF: tumour necrosis factor; MMP: matrix metalloproteinase; HSP: heat shock protein.

References

    1. Chandrashekara S., Anupama K.R., Sambarey A., Chandra N. High IL-6 and low IL-15 levels mark the presence of TB infection: A preliminary study. Cytokine. 2016;81:57–62. doi: 10.1016/j.cyto.2016.02.003. - DOI - PubMed
    1. Hoang L.T., Shimizu C., Ling L., Naim A.N., Khor C.C., Tremoulet A.H., Wright V., Levin M., Hibberd M.L., Burns J.C. Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease. Genome Med. 2014;6(11):541. doi: 10.1186/s13073-014-0102-6. - DOI - PMC - PubMed
    1. Hu P., Jiang G.M., Wu Y., Huang B.Y., Liu S.Y., Zhang D.D., Xu Y., Wu Y.F., Xia X., Wei W., Hu B. TNF-alpha is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease. Clin. Chim. Acta. 2017;471:76–80. doi: 10.1016/j.cca.2017.05.019. - DOI - PubMed
    1. Kim G.B. Reality of Kawasaki disease epidemiology. Korean J. Pediatr. 2019;62(8):292–296. - PMC - PubMed
    1. Korematsu S., Ohta Y., Tamai N., Takeguchi M., Goto C., Miyahara H., Kawano T., Izumi T. Cell distribution differences of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in patients with Kawasaki disease. Pediatr. Infect. Dis. J. 2012;31(9):973–974. doi: 10.1097/INF.0b013e31825ba6b3. - DOI - PubMed